Summary Basis of Decision for Leqembi
Health Canada published the Summary Basis of Decision for Leqembi, indicating the drug’s authorization for market entry in Canada for the treatment of Alzh…
Impact analysis · 60/100 · AI-assisted priority
This score prioritizes research; it does not predict an outcome. Method and limitations.
What happened
Health Canada published the Summary Basis of Decision for Leqembi, indicating the drug’s authorization for market entry in Canada for the treatment of Alzheimer's disease. The summary provides regulatory review details supporting approval.
Quantitative evidence
- Authorization issued August 2026
- Indication: Alzheimer’s disease
- Sponsor not specified in summary
- No pivotal trial ID, n, or effect size stated
- Sponsor not confirmed in this release
Affected entities
Analysis
The following contextual analysis is AI-assisted and separated from the reported primary-source record above.
Scientific context
Leqembi is a monoclonal antibody targeting amyloid-beta for Alzheimer’s disease. Scientific details and trial results supporting this approval are not disclosed in the summary provided.
Market context
Approval enables entry into the Canadian Alzheimer's disease market, but commercial terms and competitive positioning are unspecified in this summary.
Legal and regulatory context
This marks a completed Health Canada authorization for Leqembi, allowing marketing in Canada.
Related PharmaSignal profiles
Sources
For informational use only. Verify decisions against the linked regulator or primary source.
Evidence & limits
Source: Open the source record
- Record identifier
- 9180b09404f4d108cc8b4a1c6648aef0c3865b0c9b73cb62b429651ffa3b30a2
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- 2026-08-31T213013Z
What it supports. The linked authority’s action, within the product, indication, jurisdiction, and procedural stage stated in that record.
Limits. A committee opinion, draft, or announcement does not by itself establish final authorization. The summary and contextual analysis are AI-assisted; a source link does not establish human review.
Connection basis. Related profiles are normalized name mentions in article text. A mention does not establish a legal relationship.